The concept paper on phage therapies for human health goal is to establish a scientific guideline for the pharmaceutical development and manufacture of bacteriophage medicinal products intended for the therapeutic…
The European Medicines Agency (EMA) has accepted to review the Marketing Authorisation Application (MAA) for etranacogene dezaparvovec (EtranaDez), a gene therapy to treat hemophilia B, under its accelerated assessment procedure.…
Revio is a Regulatory Affairs Consultancy – Created to support biopharmaceutical companies and public institutions, working with Advanced Therapy Medicinal Products (ATMPs)